Related Experiment Video
Updated: Aug 22, 2025

05:06
Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy
Published on: February 28, 2025
366
Clinical utility of nailfold capillaroscopy
Peter J Roberts-Thomson1, Karen A Patterson1, Jennifer G Walker1
1Rheumatology Unit, Department of Medicine, Flinders Medical Centre, Adelaide, South Australia, Australia.
Internal Medicine Journal
|November 10, 2022
Summary
Nailfold capillaroscopy (NFC) is a simple, noninvasive technique to detect microvasculopathy in scleroderma spectrum disorders. This review highlights NFC
Area of Science:
- Rheumatology
- Dermatology
- Immunology
- Microvascular Medicine
Background:
- Nailfold capillaroscopy (NFC) is a noninvasive technique for examining nailfold capillaries.
- Microvasculopathy in nailfold capillaries is crucial in scleroderma spectrum disorders, including dermatomyositis and antisynthetase myositis.
- Current understanding of the microvasculopathy's cause is limited, but it's linked to Raynaud Phenomena and autoantibodies.
Purpose of the Study:
- To review methodologies and diagnostic utility of nailfold capillaroscopy (NFC).
- To discuss recent advances in analyzing microvascular patterns and metrics.
- To explore the potential of NFC as a biomarker for managing scleroderma spectrum disorders.
Main Methods:
- Review of existing literature on nailfold capillaroscopy (NFC) techniques.
- Discussion of diagnostic applications using bedside equipment (ophthalmoscope, dermatoscope, smartphone).
- Analysis of recent advancements in reporting abnormal microvascular patterns and vascular metrics like capillary density and dropout.
Main Results:
- NFC is a valuable diagnostic tool for identifying microvasculopathy in scleroderma spectrum disorders.
- Simple bedside techniques provide significant diagnostic utility.
- Advances enable detailed reporting of abnormal microvascular patterns and quantitative vascular metrics.
Conclusions:
- Nailfold capillaroscopy (NFC) offers a clinically accessible view into the pathology of scleroderma-related diseases.
- Wider availability of NFC is recommended in rheumatological, immunological, and dermatological practices.
- NFC shows promise as a future biomarker for managing scleroderma spectrum disorders.

